Giulia Tamborino
Principal Scientist - RLT Modeling & Simulation Novartis
Seminars
Wednesday 29th July 2026
Applying PBPK Modelling to Empower Translational Development for Radioligand Therapies (RLTs)
12:00 pm
- Understanding the nuanced challenges with developing RLTs and the rationale behind applying PBPK models
- Exploring how PBPK models take note of compound and phyisological properties of mice versus human tissues to build an understanding of radiopharmaceutical distribution
- Leveraging PBPK data to optimize toxicity and efficacy of RLTs, leading to tumor growth inhibition
